Navigation Links
Statement About Agreement With White House and Senate Finance Committee on Health Reform
Date:7/8/2009

WASHINGTON, July 8 /PRNewswire/ -- America's hospitals have long been committed to expanding coverage to the millions of Americans without health insurance. Physicians, nurses and other caregivers know all too well what lack of coverage means for far too many people. They see it in America's emergency rooms every day. As a nation, we know we can and must do better. That's why we support today's agreement with Chairman Baucus and the Obama Administration to move comprehensive health reform forward.

Now for the first time, coverage for all is within our nation's reach as the agreement based upon the Finance Committee proposal will cover 95 percent of all Americans. As we take this historic step, we recognize that everyone must do their part if we are to succeed. This proposal calls on employers, individuals, unions, suppliers, insurers and other providers to do their part as well. Make no mistake that hospitals will do our part to get virtually every American covered. The reductions of $155 billion over 10 years in the framework are substantial, are linked in part to increased coverage and cannot go any deeper without damaging hospitals' ability to care for their communities.

Today's package makes significant strides in reforming our health care delivery system. We are pleased to see restrictions on physician self-referral to hospitals in which they have an ownership interest, proposals to simplify administrative red tape and no cuts to funding that teaching hospitals rely upon to train the next generation of physicians. In addition, the disproportionate share programs (DSH) that help hospitals care for the uninsured and underinsured and support important community resources would not be reduced until 2015, and reductions would only occur if coverage expansions actually took place. Roughly 60 percent of the existing DSH payments would be preserved to support our nation's safety net.

The true test of any reform is whether it improves care for patients and helps make our nation healthier as well as ensure that hospitals, the backbone of community health care, are able to meet the challenges of caring for their communities. The public will hold any final package to that standard. We applaud the work of Senator Baucus in putting together this important framework and stand ready to work with the Senate, House and the Administration to enact comprehensive health reform that works for patients and families and the hospitals and health care professionals that serve them.

    Rich Umbdenstock       Sister Carol Keehan       Chip Kahn
    President and CEO      President and CEO         President
    American Hospital      Catholic Health           Federation of American
    Association            Association of the        Hospitals
                           United States

    Contact:
    Alicia Mitchell of AHA
    +1-202-626-2339
    Richard Coorsh of FAH
    +1-202-624-1527
    Fred Caesar of CHA
    +1-202-296-3993


'/>"/>
SOURCE American Hospital Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Statement by Jim OHara, Director, Produce Safety Project, in Response to the White House Announcement on the Proposed FDA Rule on Produce Safety
2. CareFusion Files Amended Form 10 Registration Statement With SEC
3. Montana Meth Project Statement Regarding Billings Gazette Story
4. American Society of Anesthesiologists Releases Following Statement Related to Media Inquires Regarding Michael Jacksons Death
5. Statement by John Bailey, Chief Scientist The Personal Care Products Council, Response to EWGs 2009 Sunscreen Report
6. Statement from IDF on studies suggesting possible link between insulin glargine and cancer
7. NJLRA Statement in Response to Roches Discontinuation of Accutane(R)
8. AAHSA Statement on Long-Term Services and Supports CBO Scoring
9. AAHSA Statement on House Ways and Means Committee Hearing
10. Statement of Dr. Elena Rios, MD, MSPH, President and CEO, National Hispanic Medical Association
11. Phyhealth Issues 2008 Audited Financial Statements and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... ... been recognized for excellence in employee engagement. Omaha-based C&A Industries, a national ... 50 Most Engaged Workplaces™ in North America for 2017. The annual ...
(Date:6/28/2017)... ... 2017 , ... Hayes, Inc., a leading provider of unbiased ... lineup* for its second annual Client Symposium. Joining the symposium this year are: ... of Privia Health; and Lisa Tourville of Anthem. , “We are thrilled ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... a one-day corporate governance program for mid-market executives as a kick-off to the ... held Sunday, Sept. 24, 2017 on the University of Pennsylvania campus, followed by ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... management and financial planning assistance to clients in southern Montana, is announcing a ... by Zoo Montana. , The outreach programs offered by Zoo Montana provide students ...
(Date:6/27/2017)... ... 2017 , ... Excel Medical, the leader in Next-Generation Medical ... Executive Vice President, Sales and Marketing. Finnegan is a widely known industry leader ... leadership. He has received industry recognition for innovations and new approaches to sales ...
Breaking Medicine News(10 mins):
(Date:6/20/2017)... and LAGUNA HILLS, Calif. , June ... new data that validate the use of MMprofiler with ... with multiple myeloma (MM). In a poster presentation at ... Association (EHA) in Madrid, Spain , ... for identifying high-risk elderly patients. In ...
(Date:6/14/2017)... 14, 2017  ivWatch LLC, a medical device company ... (IV) therapy, is pleased to announce it was the ... Hospital Supplies and Equipment at the 2017 Medical Design ... medtech industry. The award was presented by Medical Device ... Center in New York during ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: